These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9439500)

  • 21. Losartan-induced hepatotoxicity.
    Bosch X
    JAMA; 1997 Nov; 278(19):1572. PubMed ID: 9370501
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hypertension in patients with cardiac hypertrophy].
    Kohno M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():471-7. PubMed ID: 15171418
    [No Abstract]   [Full Text] [Related]  

  • 23. [A suitable antihypertensive drug of significance. Protection of heart, brain and kidney is decisive].
    MMW Fortschr Med; 2005 May; 147(19):49. PubMed ID: 15940939
    [No Abstract]   [Full Text] [Related]  

  • 24. [Utilizing progress in modern antihypertensive therapy. Treating hypertension effectively from the beginning].
    MMW Fortschr Med; 2005 May; 147(19):48. PubMed ID: 15940938
    [No Abstract]   [Full Text] [Related]  

  • 25. Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology.
    Chiu AG; Krowiak EJ; Deeb ZE
    Laryngoscope; 2001 Oct; 111(10):1729-31. PubMed ID: 11801934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [German Hypertension League on the LIFE Study. New evaluation of AT1 receptor antagonists].
    Dominiak P; Zidek W
    MMW Fortschr Med; 2002 Sep; 144(38):47. PubMed ID: 12395703
    [No Abstract]   [Full Text] [Related]  

  • 27. Is losartan as effective as enalapril on posttransplant persistent proteinuria?
    Altiparmak MR; Trablus S; Apaydin S; Başar O; Sariyar M; Serdengeçti K; Erek E
    Transplant Proc; 2001; 33(7-8):3368-9. PubMed ID: 11750440
    [No Abstract]   [Full Text] [Related]  

  • 28. Angiotensin II receptor antagonists: what future?
    Onuigbo M
    South Med J; 1998 Aug; 91(8):794-6. PubMed ID: 9715233
    [No Abstract]   [Full Text] [Related]  

  • 29. Losartan associated anaphylaxis and angioneurotic oedema.
    Kazim SF; Shahid M
    J Pak Med Assoc; 2010 Aug; 60(8):685-6. PubMed ID: 20726206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D; Moritz ML; Vats A; Janosky JE
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new class of antihypertensive: angiotensin II receptor antagonists.
    McCoy R
    S D J Med; 1995 Sep; 48(9):319-20. PubMed ID: 7481726
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of the antihypertensive effects of candesartan cilexetil and losartan in patients with mild to moderate hypertension.
    Andersson OK; Neldam S
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S63-4. PubMed ID: 9331011
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical safety and tolerability of losartan.
    Weber M
    Clin Ther; 1997; 19(4):604-16; discussion 603. PubMed ID: 9377606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of severe proteinuria with losartan after renal transplantation.
    Navarro JF; Macía ML; García J
    Am J Nephrol; 1998; 18(3):261-2. PubMed ID: 9627049
    [No Abstract]   [Full Text] [Related]  

  • 35. [What are the consequences of the LIFE Study for general practice].
    Zidek W
    MMW Fortschr Med; 2002 Sep; 144(38):48. PubMed ID: 12395704
    [No Abstract]   [Full Text] [Related]  

  • 36. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
    Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Isolated systolic hypertension. "AT1 blocker preferred over beta-blocker"].
    MMW Fortschr Med; 2002 Sep; 144(38):14. PubMed ID: 12395694
    [No Abstract]   [Full Text] [Related]  

  • 38. [Organ protection by angiotensin II receptor blockers].
    Kumagai H; Onami T; Takimoto C; Iigaya K; Saruta T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():569-73. PubMed ID: 15171437
    [No Abstract]   [Full Text] [Related]  

  • 39. [A possible adverse effect from the association of losartan-mefenamic acid in hemodialysis].
    Khazine F; Simons O
    Nephrologie; 2001; 22(2):73. PubMed ID: 11385903
    [No Abstract]   [Full Text] [Related]  

  • 40. Losartan-induced angioedema.
    Rivera JO
    Ann Pharmacother; 1999 Sep; 33(9):933-5. PubMed ID: 10492493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.